Sue Gail Eckhardt

Insider Reports History

Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Signature
/s/ Nina Ayer, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sue Gail Eckhardt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXELIXIS, INC. Director Common Stock 21.4K $934K $43.67 Jun 2, 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 16K $79.2K $4.95 Jun 5, 2024 Direct
EXELIXIS, INC. Director Option (right to buy) 23.1K Feb 14, 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct

Insider Reports Filed by Sue Gail Eckhardt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EXEL EXELIXIS, INC. Jun 2, 2025 2 -$805K 4 Jun 4, 2025 Director
EXEL EXELIXIS, INC. May 29, 2025 1 $0 4 May 30, 2025 Director
EXEL EXELIXIS, INC. Feb 14, 2025 4 -$226K 4 Feb 19, 2025 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
EXEL EXELIXIS, INC. May 31, 2024 1 $0 4 Jun 4, 2024 Director
EXEL EXELIXIS, INC. Jan 5, 2024 2 $0 4 Jan 9, 2024 Director
EXEL EXELIXIS, INC. Jan 5, 2024 0 $0 3 Jan 9, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director